← 返回

CAR 巨噬细胞调控抗癌治疗的免疫交响乐

英文原题:CAR macrophages tuning the immune symphony of anti-cancer therapies.

查看英文原题

CAR macrophages tuning the immune symphony of anti-cancer therapies.

PubMed 2024/06/06(内容时间) Cell Stem Cell Q1 · IF 23.3(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

嵌合抗原受体(CAR)巨噬细胞拓宽了抗癌免疫治疗的版图,以对抗实体恶性肿瘤。Shah等人引入CAR以促进CAR巨噬细胞疗法,该疗法旨在招募并激活T/NK 细胞,进一步加强整体免疫反应,以减轻胰腺癌负荷和转移扩散。

展开英文摘要原文

Chimeric antigen receptor (CAR) macrophages have broadened the landscape of anti-cancer immunotherapies to combat solid malignancies. Shah et al. introduce CARs to facilitate a CAR macrophage therapy, which aims to recruit and activate T/natural killer cells, further strengthening the overall immune response to decrease pancreatic cancer burden and metastatic spreading.

论文信息

作者
Paasch D、Lachmann N
第一作者单位
Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, 30625 Hannover, Germany.Germany
通讯作者单位
Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, 30625 Hannover, Germany; RESIST, Cluster of Excellence, Hannover Medical School, 30625 Hannover, Germany; Biomedical Research in End Stage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany; Center of Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, 30625 Hannover, Germany. Electronic address: lachmann.nico@mh-hannover.de.Germany
文献类型
评论
期刊
Cell stem cell2024 Jun 6
原文标识
PubMed 38848684 · DOI 10.1016/j.stem.2024.05.006